4
Changes in Ownership
Arbutus Biopharma Corp Filed Acc 0001140361-18-018859
Options or other derivatives
- Chief Development Officer acquired 30,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Symonds William T. · Chief Development Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2018-04-16 | Grant or award : show line 1 in the form Employee Stock Option (Right to Buy) | +30,000 | 30,000 | D |
Loading xslF345X03/doc1.xml…